Talphera, Inc. SEC filings TLPH
Talphera, Inc. has 962 filings in SEC EDGAR's recent list, going back to Feb 19, 2008. Its latest annual report, Form 10-K, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 22, 2026 |
| DEFA14A | Additional proxy material | Sep 9, 2025 | — |
| DEF 14A | Proxy statement | Sep 9, 2025 | Oct 23, 2025 |
| PRE 14A | Preliminary proxy statement | Aug 29, 2025 | Oct 23, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 24, 2024 |
| DEFA14A | Additional proxy material | Oct 5, 2023 | — |
| DEFA14A | Additional proxy material | Aug 28, 2023 | — |
| DEF 14A | Proxy statement | Aug 28, 2023 | Oct 10, 2023 |
| DEFA14A | Additional proxy material | Aug 12, 2022 | — |
| DEF 14A | Proxy statement | Aug 12, 2022 | Sep 23, 2022 |
| PRE 14A | Preliminary proxy statement | Aug 3, 2022 | Aug 3, 2022 |
| DEFA14A | Additional proxy material | Jul 18, 2022 | — |
| DEFA14A | Additional proxy material | Jun 3, 2022 | — |
| DEF 14A | Proxy statement | Jun 3, 2022 | Jul 15, 2022 |
| PRE 14A | Preliminary proxy statement | May 24, 2022 | Jul 15, 2022 |
| DEFA14A | Additional proxy material | Apr 23, 2021 | — |
| DEF 14A | Proxy statement | Apr 23, 2021 | Jun 17, 2021 |
| DEFA14A | Additional proxy material | Apr 24, 2020 | — |
| DEF 14A | Proxy statement | Apr 24, 2020 | Jun 16, 2020 |
| DEFA14A | Additional proxy material | May 14, 2019 | — |
| DEF 14A | Proxy statement | May 14, 2019 | Jun 25, 2019 |
| PRE 14A | Preliminary proxy statement | May 3, 2019 | Jun 25, 2019 |
| DEFA14A | Additional proxy material | Apr 23, 2018 | — |
| DEF 14A | Proxy statement | Apr 23, 2018 | Jun 14, 2018 |
| DEFA14A | Additional proxy material | Apr 28, 2017 | — |
| DEF 14A | Proxy statement | Apr 28, 2017 | Jun 15, 2017 |
| DEFA14A | Additional proxy material | Apr 28, 2016 | — |
| DEF 14A | Proxy statement | Apr 28, 2016 | Jun 21, 2016 |
| DEFA14A | Additional proxy material | Apr 30, 2015 | — |
| DEF 14A | Proxy statement | Apr 30, 2015 | Jun 23, 2015 |
| DEF 14A | Proxy statement | Jun 20, 2014 | Jul 24, 2014 |
| DEF 14A | Proxy statement | Aug 6, 2013 | Sep 12, 2013 |
| DEF 14A | Proxy statement | Jun 21, 2012 | Jul 24, 2012 |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TLPH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Mateo, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1427925
- Former names
- ACELRX PHARMACEUTICALS INC (until Dec 14, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.